Cisplatin (Cervical Cancer) - Analysis and Forecasts to 2020

April 3, 2012 - PRLog -- It covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020).

The report also includes information on Cervical Cancer market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

For sample pages and further information concerning the report Cisplatin (Cervical Cancer) - Analysis and Forecasts to 2020 please visit: http://www.globalmarketsdirect.com/SamplePdfRequest.aspx?ID=The-Enhanced-Oil-Recovery-EOR-Technologies-Market-2012-2022&Title=Energy_and_Utilities&ReportType=Industry_Report&companyID=prlog

Scope

Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
Analysis and review of Cisplatin including sales data
Qualitative and quantitative assessment of market space
Analysis of the trends, drivers and restraints shaping and defining the markets
In-depth analysis of Cisplatin including efficacy, safety, pricing, competition and other details which influence its sales potential
Detailed sales forecast for 2002-2020 for Cisplatin in the seven major markets

Reasons to buy

Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
Examine the historical sales performance of a drug in seven major markets
Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

For more information about this report please email:
pressreleases@globalmarketsdirect.com
Asia Pacific:       +91 40 6616 6782

About Global Markets Direct
The Global Markets Direct Report Store features thousands of high quality company and market research reports across a broad range of industries. Browse or search our collection of reports today to access the latest in business intelligence from some of the world’s leading publishers.